Fernand Labrie

Publications

Page 4 of 4, showing 37 records out of 187 total, starting on record 151, ending on 187

Publication Category Year
37. Luthy, I.A., Bégin, D.J., Labrie, F. (1988) Androgenic activity of synthetic progestins and spironolactone in androgen-sensitive mouse mammary carcinoma (Shionogi) cells in culture. J. Steroid Biochem., 31: 845-852. Breast Cancer 1988
36. Plante, M., Lapointe, S., Labrie, F. (1988) Stimulatory effect of synthetic progestins currently used for the treatment of prostate cancer on growth of the androgen-sensitive Shionogi tumor in mice. J. Steroid Biochem., 31: 61-64. Breast Cancer 1988
35. Dauvois, S., Labrie, F. (1988) Androstenedione (4-dione) is a potent stimulus for the growth of dimethylbenz(a)anthracene (DMBA)-induced mammary tumors in the rat, in: 1st Congress of the International Society of Gynecological Endocrinology, Crans-Montana, Switzerland, pp 626-630. Breast Cancer 1988
34. Labrie, F., Veilleux, R., Fournier, A. (1988) Glucocorticoids stimulate the growth of mouse mammary carcinoma Shionogi cells in culture. Mol. Cell. Endocrinol., 58: 207-211. Breast Cancer 1988
33. Poirier, D., Poulin, R., Labrie, F. (1988) Screening of lipoidal steroid formation in the ZR-75-1 human breast cancer cell line, in: Bresciani, F., King, R.J.B., Lippman, M.E. et Raynaud, J.P., eds: Progress in Cancer Research and Therapy. Hormones and Cancer, New York, Raven Press, pp 384-387. Breast Cancer 1988
32. Poulin, R., Baker, D., Labrie, F. (1988) Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line. Breast Cancer Res. Treat., 12: 213-225. Breast Cancer 1988
31. Poulin, R., Mérand, Y., Labrie, F. (1988) Antiestrogenic properties of a 7?-alkylated derivative of 17?-estradiol in ZR-75-1 human breast cancer, in: Genazzani, A.R., Petraglia, F., Volpe, A. et Facchinetti, F., eds: Recent Research in Gynecological Endocrinology, Parthenon Publishing Group, pp 631-634. Breast Cancer 1988
30. Spinola, P.G., Marchetti, B., Mérand, Y., Labrie, F. (1988) Effects of the aromatase inhibitor 4-hydroxyandrostenedione and antiandrogen flutamide on growth and steroid levels in DMBA-induced rat mammary tumors. Breast Cancer Res. Treat., 12: 287-296. Breast Cancer 1988
29. Luthy, I., Caron, S., Bélanger, A., Labrie, F. (1987) Effect of flutamide, a pure antiandrogen, on the pituitary-ovarian axis in the adult female rat. Gynecol. Endocrinol., 1: 151-168. Breast Cancer 1987
28. Poulin, R., Labrie, F. (1987) Estrogenic effect of adrenal steroids in the human mammary carcinoma cell line ZR-75-1, in: Genazzani, A.R., Volpé, A. et Facchinetti, F., eds: Proceedings of the First International Congress on Gynecological Endocrinology, London, Parthenon Publishig Group, pp 561-568. Breast Cancer 1987
27. Simard, J., Labrie, F. (1987) Adrenal C19-5-ene steroids induce full estrogenic responses in rat pituitary gonadotrophs. J. Steroid Biochem., 26: 539-546. Breast Cancer 1987
26. Labrie, F., Veilleux, R. (1986) A wide range of sensitivities to androgens develops in cloned Shionogi mouse mammary tumor cells. Prostate, 8: 293-300. Breast Cancer 1986
25. Poulin, R., Labrie, F. (1986) Stimulation of cell proliferation and estrogenic response by adrenal C19-?5-steroids in the ZR-75-1 human breast cancer cell line. Cancer Res., 46: 4933-4937. Breast Cancer 1986
24. Simard, J., Labrie, F., Gossard, F. (1986) Regulation of growth hormone mRNA and pro-opiomelanocortin mRNA levels by cyclic AMP in rat anterior pituitary cells in culture. DNA, 5: 263-270. Breast Cancer 1986
23. Spinola, P.G., Marchetti, B., Labrie, F. (1986) Adrenal steroids stimulate growth and progesterone receptor levels in rat uterus and DMBA-induced mammary tumors. Breast Cancer Res. Treat., 8: 241-248. Breast Cancer 1986
22. Bélanger, A., Le Goff, J.M., Proulx, L., Caron, S., Labrie, F. (1985) Presence of C-19 steroids in mammary Shionogi carcinoma (SC 115) in castrated mice. Cancer Res., 45: 6293-6295. Breast Cancer 1985
21. Labrie, F. (1981) Changing the message from the brain. People, 8: 16-17. Breast Cancer 1981
20. Labrie, F., Bélanger, A., Séguin, C., Cusan, L., Pelletier, G., Lefebvre, F.A., Kelly, P.A., Ferland, L., Reeves, J.J., Lemay, A., Raynaud, J.P. (1981) Inhibition of testicular and ovarian functions by LHRH agonists, in: Jagiello, G. et Vogel, H.J., eds: Bioregulators of Reproduction, New York, NY, USA, Academic Press, pp 305-341. Breast Cancer 1981
19. Labrie, F., Bélanger, A., Séguin, C., Pelletier, G., Kelly, P.A., Lefebvre, F.A., Massicotte, J., Borgus, J.P., Lemay, A., van der Ohe, M. (1981) Antifertility effects of LHRH agonists, in: Semm, K. et Mettler, L., eds: Proc. III World Congress on Human Reproduction, Excerta Medica, ICS 551, pp 116-125. Breast Cancer 1981
18. Labrie, F., Bélanger, A., Séguin, C., Pelletier, G., Lefebvre, F.A., Massicotte, J., Kelly, P.A., Borgus, J.P. (1981) LHRH and sexual functions: inhibition at the pituitary and gonadal levels, in: Bizollon, C.A., ed. Physiological peptides and new trends in radioimmunology, Elsevier-North Holland, Biomedical Press, pp 57-70. Breast Cancer 1981
17. Turcot-Lemay, L., Cusan, L., Séguin, C., Kelly, P.A., Labrie, F. (1981) Effect of an LHRH analog on growth and hormone receptor levels in dimethylbenz(?)anthracene-induced mammary tumors in the rat. J. Receptor Res., 2: 135-151. Breast Cancer 1981
16. Cusan, L., Auclair, C., Bélanger, A., Ferland, L., Kelly, P.A., Séguin, C., Labrie, F. (1979) Inhibitory effects of long-term treatment with an LHRH agonist on the pituitary-gonadal axis in male and female rats. Endocrinology, 104: 1369-1376. Breast Cancer 1979
15. Labrie, F., Auclair, C., Cusan, L., Lemay, A., Pelletier, G., Kelly, P.A., Bélanger, A., Séguin, C., Raynaud, J.P. (1979) Antifertility effects of LHRH and its agonists in male and female rats: possible luteolytic effects of LHRH in women, in: Talwar, G.P., ed. Recent Advances in Reproduction and Regulation of Fertility, Elsevier-North Holland, Biomedical Press, pp 57-71. Breast Cancer 1979
14. Asselin, J., Mélançon, R., Moachon, G., Labrie, F. (1979) Récepteurs hormonaux, in: Dionne, L. et Plante, M., eds: Cancer du Sein: Breast Cancer, Les Presses de l'Université Laval, pp 41-46. Breast Cancer 1979
13. Kelly, P.A., Asselin, J., Labrie, F. (1979) Endocrine regulation of growth and hormone receptor levels in DMBA-induced mammary tumors, in: Thompson, E.B. et Lippman, M.E., eds: Steroids Receptors and the Management of Cancer, Boca Raton, Florida, CRC Press Inc., pp 3-29. Breast Cancer 1979
12. Kelly, P.A., Asselin, J., Turcot-Lemay, L., Labrie, F., Raynaud, J.P. (1979) Effects of progesterone and R2323 on the development of dimethylbenz(??anthracene-induced mammary tumors. Eur. J. Cancer, 15: 1243-1251. Breast Cancer 1979
11. Auclair, C., Cusan, L., Kledzik, G.S., Ferland, L., Kelly, P.A., Labrie, F. (1978) Inhibition de fonctions gonadiques par la LHRH et ses agonistes chez le rat mâle et femelle. Union Med. Can., 107: 356-364. Breast Cancer 1978
10. Asselin, J., Labrie, F. (1978) Effects of estradiol and prolactin on steroid receptor levels in 7,12-dimethylbenz(a)anthracene-induced mammary tumors and uterus in the rat. J. Steroid Biochem., 9: 1079-1082. Breast Cancer 1978
9. Asselin, J., Kelly, P.A., Caron, M.G., Labrie, F. (1977) Control of hormone receptor levels and growth of 7,12-dimethylbenz(a)anthracene-induced mammary tumors by estrogens, progesterone and prolactin. Endocrinology, 101: 666-671. Breast Cancer 1977
8. Kelly, P.A., Asselin, J., Caron, M.G., Labrie, F., Raynaud, J.P. (1977) Potent inhibitory effect of a new antiestrogen (RU16117) on the growth of 7,12-dimethylbenz(?)anthracene (DMBA)-induced mammary tumors. J. Natl. Cancer Inst., 58: 623-628. Breast Cancer 1977
7. Kelly, P.A., Asselin, J., Caron, M.G., Raynaud, J.P., Labrie, F. (1977) High inhibitory activity of a new antiestrogen RU16117 (11?-methoxy-ethinyl estradiol) on the development of dimethylbenz(?)anthracene-induced mammary tumors. Cancer Res., 37: 76-81. Breast Cancer 1977
6. Kelly, P.A., Asselin, J., Labrie, F., Raynaud, J.P. (1977) Regulation of hormone receptor levels and growth of DMBA-induced mammary tumors by RU16117 and other steroids in the rat, in: McGuire, W.L., Baulieu, E.E. et Raynaud, J.P., eds: Progesterone Receptors in Normal and Neoplastic Tissues, New-York, Raven Press, pp 85-101. Breast Cancer 1977
5. Coy, D.H., Labrie, F., Savary, M., Coy, E.J., Schally, A.V. (1976) Antagonistic activity of analogs of luteinizing hormone-releasing hormone (LHRH) in vitro. Mol. Cell. Endocrinol., 5: 201-208. Breast Cancer 1976
4. Ferland, L., Labrie, F., Savary, M., Beaulieu, M., Coy, D.H., Coy, E.J., Schally, A.V. (1976) Inhibitory activity of analogues of luteinizing hormone-releasing hormone (LH-RH) in vitro and in vivo. Clin. Endocrinol. (Oxf.), 5: 279S-289S. Breast Cancer 1976
3. Labrie, F., Savary, M., Coy, D.H., Coy, E.J., Schally, A.V. (1976) Inhibition of luteinizing hormone release by analogs of luteinizing hormone-releasing hormone (LHRH) in vitro. Endocrinology, 98: 289-94. Breast Cancer 1976
2. Asselin, J., Labrie, F., Kelly, P.A., Philibert, D., Raynaud, J.P. (1976) Specific progesterone receptors in dimethylbenzanthracene (DMBA)-induced mammary tumors. Steroids, 27: 395-404. Breast Cancer 1976
1. Labrie, F., Kelly, J., Asselin, J., Raynaud, J.P. (1976) Potent inhibitory activity of a new antiestrogen, RU 16117, on the development and growth of DMBA-induced rat mammary adenocarcinoma, in: St. Arneault, G., Band, P. et Israel, L., eds: Recent results in Cancer Research, Breast Cancer, a multidisciplinary approach, Springer-Verlag, pp 109-120. Breast Cancer 1976
<< previous | 1 | 2 | 3 | 4
next >>

Biography  |  Publications  |  Scientific Conferences  |  Selected Slide Presentations  |  Awards